[A new feasibility of immune stimulation in diseases with reduced cell immunity? (author's transl)].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D001388:Aziridines / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D008297:Male; D008875:Middle Aged; D012507:Sarcoidosis / Q000276:immunology* / Q000628:therapy
D000276:Adjuvants, Immunologic; D001388:Aziridines; D001389:Azirines; C016866:azimexon
Nová moznost imunostimulace u chorob se snizenou bunĕcnou imunitou?